Cybin (OTCMKTS:CLXPF) Reaches New 52-Week High at $9.75

Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $9.75 and last traded at $9.60, with a volume of 329618 shares changing hands. The stock had previously closed at $9.88. Cybin Stock Performance The stock has a market cap of [...]

featured-image

Cybin Inc. ( OTCMKTS:CLXPF – Get Free Report ) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $9.

75 and last traded at $9.60, with a volume of 329618 shares changing hands. The stock had previously closed at $9.



88. Cybin Stock Performance The stock has a market cap of $1.43 billion and a P/E ratio of -41.

17. The stock’s fifty day moving average is $1.38 and its 200 day moving average is $0.

70. Cybin Company Profile ( Get Free Report ) Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey.

The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. Featured Articles Five stocks we like better than Cybin The Top 3 Healthcare Dividend Stocks to Buy and Hold Can Costco Stock Hit New Highs as Interest Rates Drop? How to Know if a Stock Pays Dividends and When They Are Paid Out These 3 Stocks Show How to Navigate Declining Consumer Confidence 3 Ways To Invest In Coffee, Other Than Drinking It MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy? Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter .

.